PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2009 | 65 | 04 |

Tytuł artykułu

Zastosowanie krwi i produktow krwiopochodnych w leczeniu zaburzen immunologicznych zrebiat

Warianty tytułu

EN
Use of blood and derivative products in the immunological disease treatment of foals

Języki publikacji

PL

Abstrakty

EN
Conditions common to foals in the neonatal period that may result in a requirement for blood and plasma transfusion or augmentation of oxygen carrying capacity have been discussed. Methods of recognition and management of massive blood loss, isoerythrolysis in a foal were described. Administering colostrum, plasma or other products because of the failure of passive transfer has been presented. The use of hyperimmune plasma in first days of life as an effective method for protection against acquired Rhodococcus equi pneumonia in foals is reviewed. Detailed information about the range of blood and derivative products, oxygen carrying substances, indications and methods of administration, monitoring the patient in the field and hospital condition are given. Prevention, recognition and treatment of possible post-transfusion reactions are described.

Wydawca

-

Rocznik

Tom

65

Numer

04

Opis fizyczny

s.241-244,bibliogr.

Twórcy

autor
  • Uniwersytet Przyrodniczy we Wroclawiu, pl.Grunwaldzki 51, 50-366 Wroclaw

Bibliografia

  • 1.Bain F.: Colloid therapy in equine patients. Proc. 7th International Veterinary Emergency and Critical Care Symposium, Orlando 2000, s. 655-657.
  • 2.Baldwin J., Cooper W., Vanderwall D., Erb H.: Prevalence (treatment days) and severity of illness in hypogammaglobulinemic and normogammaglobulinemic foals. J. Am. Vet. Med. Assoc. 1991, 198, 423-428.
  • 3.Clabough D., Levine J., Grant G., Conboy H.: Factors associated with failure of passive transfer of colostral antibodies in standardbred foals. J. Vet. Intern. Med. 1991, 5, 335-340.
  • 4.Crump L., Foreman J., Riddle W.: Evaluation of hyperimmune equine plasma for the treatment of failure of passive transfer in foals. Proc. Ann. Conv. Am. Assoc. Equine Pract. 1992, 37, 9-15.
  • 5.Giger U., Rentko V.: Alternatives to blood transfusions. Proc. 16th ACVIM Forum 2002, s. 430-431.
  • 6.Hunt E., Wood B.: Use of blood and blood products. Vet. Clin. North Am. Food Pract. 1999, 15, 641-662.
  • 7.Jeffcott L.: Current Therapy in Equine Medicine. Saunders W. B., Philadelphia 1987, 210-215.
  • 8.Koterba A., Drummond W., Kosch P.: Equine Clinical Neonatology, Lea&Febiger, Philadelphia 1990.
  • 9.LeBlanc M.: Responses to plasma transfusion in clinically healthy and clinically ill foals. Proc. AAEP New Orleans 1987, 755-761.
  • 10.Madigan J. E., Hietala S., Muller N.: Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma. J. Reprod. Fert. 1991, 44, 571-578.
  • 11.Martens R. J., Martens J. G., Fiske R. A.: Rhodococcus equi foal pneumonia: Protective effects of immune plasma in experimentally infected foals. Equine Vet. J. 1989, 21, 249-255.
  • 12.McClure J., DeLuca J., Lunn D., Miller J.: Evaluation of IgG concentration and IgG subisotypes in foals with complete or partial failure of passive transfer after administration of intravenous serum or plasma. Eq. Vet. J. 2001, 33, 681-686.
  • 13.Perkins G., Divers T.: Polymerized hemoglobin treatment in a foal with neonatal isoerythrolysis. J. Vet. Emerg. Crit. Care 2001, 11, 141-145.
  • 14.Smith J., Dever M., Smith J., DeBowes M.: Post-transfusion survival of 5°Cr-labelled erythrocytes in neonatal foals. J. Vet. Intern. Med. 1992, 6, 183-185.
  • 15.Sprayberry K.: Neonatal transfusion medicine: The use of blood, plasma, oxygen-carrying solutions and adjunctive therapies in foals. Clin. Techniq. Eq. Pract. 2003, 2, 31-41.
  • 16.Sprayberry K., Bain F., Seahorn T., SIovis N., Byars T.: 56 Cases of rib fractures in neonatal foals hospitalized in a referral center intensive care unit from 1997-2001. Proc. AAEP San Diego 2001, s. 395-398.
  • 17.Traub-Dargatz J., McClure J., Koch C., Schlipf J.: Neonatal isoerythrolysis in mule foals. J. Am. Vet. Med. Assoc. 1995, 206, 67-70.
  • 18.Wilkins P., Dewan M.: Efficacy of intravenous plasma to transfer passive immunity in clinically healthy and clinically ill equine neonates with failure of passive transfer. Cornell Vet. 1994, 84, 7-14.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-b69c03c5-5b62-49ee-a1a0-10ea39d6910d
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.